Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Total Enrollment
9256 participants
Study Classification
OBSERVATIONAL
Study Start Date
2007-08-31
Study Completion Date
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this project is to remove barriers to obtaining contraceptive methods, including the most effective and expensive methods. The study seeks to remove the financial and knowledge barriers and promote the most effective contraceptive methods to reduce unintended pregnancy rates at the population level.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Web-Based Tool to Help People With Health Conditions Make Contraceptive Decisions
NCT07075536
Contraceptive Usage
Contraceptive Behavior
Chronic Disease
+2 more
ENROLLING_BY_INVITATION
NA
Increased Access to Emergency Contraceptive Pills
NCT00060463
Pregnancy
Sexually Transmitted Diseases
UNKNOWN
NA
Contraceptive Awareness and Reproductive Education
NCT01132950
Contraception
Sexually Transmitted Diseases
Pregnancy
UNKNOWN
NA
Project for Reproductive Equity Through Volunteers and Entrepreneurship, Networks and Technology
NCT03995043
Contraception
Pregnancy Related
Reproductive Behavior
NOT_YET_RECRUITING
NA
Helping People With Health Conditions Make Birth Control Decisions
NCT03153644
Contraception
Chronic Disease
COMPLETED
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Unintended Pregnancy
Teen Births
Abortion
Contraception
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
COHORT
Study Time Perspective
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. 14-45 years of age
2. Primary residency in St. Louis City or County
3. Does not desire pregnancy during the next 1 year
4. Desires reversible contraception
5. Sexually active with a man within the past 6 months or intend to have sex with a man in the next 6 months
6. Is not currently using a contraceptive method, has begun using a new contraceptive method within the last 4 weeks, or is a current contraceptive method user who wants to switch to a NEW contraceptive method immediately
7. Willing and able to undergo informed consent
8. Willing to comply with study protocol and 2-year follow-up schedule
9. Not currently pregnant, or meets one of the following criteria:
1. Currently pregnant, undergoing medical or surgical termination of pregnancy, and planning for post-abortion contraception
2. Currently pregnant with an abnormal pregnancy (miscarriage or ectopic pregnancy), undergoing medical or surgical management, and planning for post-pregnancy contraception
3. Currently pregnant, estimated gestational age of 36 weeks or greater, and planning for post-partum contraception.
2. Primary residency in St. Louis City or County
3. Does not desire pregnancy during the next 1 year
4. Desires reversible contraception
5. Sexually active with a man within the past 6 months or intend to have sex with a man in the next 6 months
6. Is not currently using a contraceptive method, has begun using a new contraceptive method within the last 4 weeks, or is a current contraceptive method user who wants to switch to a NEW contraceptive method immediately
7. Willing and able to undergo informed consent
8. Willing to comply with study protocol and 2-year follow-up schedule
9. Not currently pregnant, or meets one of the following criteria:
1. Currently pregnant, undergoing medical or surgical termination of pregnancy, and planning for post-abortion contraception
2. Currently pregnant with an abnormal pregnancy (miscarriage or ectopic pregnancy), undergoing medical or surgical management, and planning for post-pregnancy contraception
3. Currently pregnant, estimated gestational age of 36 weeks or greater, and planning for post-partum contraception.
Exclusion Criteria
1. History of hysterectomy or sterilization
2. Current participation in another research study that would interfere with the conduct of this study
2. Current participation in another research study that would interfere with the conduct of this study
Minimum Eligible Age
14 Years
Maximum Eligible Age
45 Years
Eligible Sex
FEMALE
Accepts Healthy Volunteers
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeffrey Peipert
Robert J. Terry Professor
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffrey F Peipert, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington University in St. Louis School of Medicine
St Louis, Missouri, United States
Site Status
Countries
Review the countries where the study has at least one active or historical site.
United States
References
Explore related publications, articles, or registry entries linked to this study.
Tepe M, Mestad R, Secura G, Allsworth JE, Madden T, Peipert JF. Association between tampon use and choosing the contraceptive vaginal ring. Obstet Gynecol. 2010 Apr;115(4):735-739. doi: 10.1097/AOG.0b013e3181d41c4a.
Reference Type
RESULT
Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol. 2010 Aug;203(2):115.e1-7. doi: 10.1016/j.ajog.2010.04.017. Epub 2010 Jun 11.
Reference Type
RESULT
Spain JE, Peipert JF, Madden T, Allsworth JE, Secura GM. The Contraceptive CHOICE Project: recruiting women at highest risk for unintended pregnancy and sexually transmitted infection. J Womens Health (Larchmt). 2010 Dec;19(12):2233-8. doi: 10.1089/jwh.2010.2146. Epub 2010 Sep 11.
Reference Type
RESULT
Pittman ME, Secura GM, Allsworth JE, Homco JB, Madden T, Peipert JF. Understanding prescription adherence: pharmacy claims data from the Contraceptive CHOICE Project. Contraception. 2011 Apr;83(4):340-5. doi: 10.1016/j.contraception.2010.08.003. Epub 2010 Sep 17.
Reference Type
RESULT
Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, Secura G. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011 May;117(5):1105-1113. doi: 10.1097/AOG.0b013e31821188ad.
Reference Type
RESULT
Kittur ND, Secura GM, Peipert JF, Madden T, Finer LB, Allsworth JE. Comparison of contraceptive use between the Contraceptive CHOICE Project and state and national data. Contraception. 2011 May;83(5):479-85. doi: 10.1016/j.contraception.2010.10.001. Epub 2010 Nov 23.
Reference Type
RESULT
Kossler K, Kuroki LM, Allsworth JE, Secura GM, Roehl KA, Peipert JF. Perceived racial, socioeconomic and gender discrimination and its impact on contraceptive choice. Contraception. 2011 Sep;84(3):273-9. doi: 10.1016/j.contraception.2011.01.004. Epub 2011 Feb 21.
Reference Type
RESULT
Mestad R, Secura G, Allsworth JE, Madden T, Zhao Q, Peipert JF. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception. 2011 Nov;84(5):493-8. doi: 10.1016/j.contraception.2011.03.001. Epub 2011 Apr 27.
Reference Type
RESULT
Graseck AS, Secura GM, Allsworth JE, Madden T, Peipert JF. Home screening compared with clinic-based screening for sexually transmitted infections. Obstet Gynecol. 2010 Apr;115(4):745-752. doi: 10.1097/AOG.0b013e3181d4450d.
Reference Type
RESULT
Graseck AS, Secura GM, Allsworth JE, Madden T, Peipert JF. Home compared with clinic-based screening for sexually transmitted infections: a randomized controlled trial. Obstet Gynecol. 2010 Dec;116(6):1311-1318. doi: 10.1097/AOG.0b013e3181fae60d.
Reference Type
RESULT
Shih SL, Kebodeaux CA, Secura GM, Allsworth JE, Madden T, Peipert JF. Baseline correlates of inconsistent and incorrect condom use among sexually active women in the contraceptive CHOICE Project. Sex Transm Dis. 2011 Nov;38(11):1012-9. doi: 10.1097/OLQ.0b013e318225f8c3.
Reference Type
RESULT
Madden T, Secura GM, Allsworth JE, Peipert JF. Comparison of contraceptive method chosen by women with and without a recent history of induced abortion. Contraception. 2011 Dec;84(6):571-7. doi: 10.1016/j.contraception.2011.03.018. Epub 2011 May 4.
Reference Type
RESULT
Madden T, Proehl S, Allsworth JE, Secura GM, Peipert JF. Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial. Am J Obstet Gynecol. 2012 Feb;206(2):129.e1-8. doi: 10.1016/j.ajog.2011.09.021. Epub 2011 Sep 24.
Reference Type
RESULT
Madden T, Grentzer JM, Secura GM, Allsworth JE, Peipert JF. Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study. Sex Transm Dis. 2012 Mar;39(3):217-22. doi: 10.1097/OLQ.0b013e31823e68fe.
Reference Type
RESULT
Skala SL, Secura GM, Peipert JF. Factors associated with screening for sexually transmitted infections. Am J Obstet Gynecol. 2012 Apr;206(4):324.e1-6. doi: 10.1016/j.ajog.2012.02.020. Epub 2012 Feb 28.
Reference Type
RESULT
Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, Secura GM. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012 May 24;366(21):1998-2007. doi: 10.1056/NEJMoa1110855.
Reference Type
RESULT
Peipert JF, Madden T, Allsworth JE, Secura GM. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol. 2012 Dec;120(6):1291-7. doi: 10.1097/aog.0b013e318273eb56.
Reference Type
RESULT
Secura GM, Desir FA, Mullersman JL, Madden T, Allsworth JE, Peipert JF. Predictors of male partner treatment for sexually transmitted infection. Sex Transm Dis. 2012 Oct;39(10):769-75. doi: 10.1097/OLQ.0b013e31825ec611.
Reference Type
RESULT
McNicholas C, Peipert JF, Maddipati R, Madden T, Allsworth JE, Secura GM. Sexually transmitted infection prevalence in a population seeking no-cost contraception. Sex Transm Dis. 2013 Jul;40(7):546-51. doi: 10.1097/OLQ.0b013e31829529eb.
Reference Type
RESULT
Eisenberg DL, Secura GM, Madden TE, Allsworth JE, Zhao Q, Peipert JF. Knowledge of contraceptive effectiveness. Am J Obstet Gynecol. 2012 Jun;206(6):479.e1-9. doi: 10.1016/j.ajog.2012.04.012. Epub 2012 Apr 6.
Reference Type
RESULT
Madden T, Mullersman JL, Omvig KJ, Secura GM, Peipert JF. Structured contraceptive counseling provided by the Contraceptive CHOICE Project. Contraception. 2013 Aug;88(2):243-9. doi: 10.1016/j.contraception.2012.07.015. Epub 2012 Sep 5.
Reference Type
RESULT
Xu H, Wade JA, Peipert JF, Zhao Q, Madden T, Secura GM. Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women. Obstet Gynecol. 2012 Jul;120(1):21-6. doi: 10.1097/AOG.0b013e318259565a.
Reference Type
RESULT
Rosenstock JR, Peipert JF, Madden T, Zhao Q, Secura GM. Continuation of reversible contraception in teenagers and young women. Obstet Gynecol. 2012 Dec;120(6):1298-305. doi: 10.1097/aog.0b013e31827499bd.
Reference Type
RESULT
Nault AM, Peipert JF, Zhao Q, Madden T, Secura GM. Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate. Am J Obstet Gynecol. 2013 Jan;208(1):48.e1-8. doi: 10.1016/j.ajog.2012.10.876. Epub 2012 Oct 24.
Reference Type
RESULT
Stuart JE, Secura GM, Zhao Q, Pittman ME, Peipert JF. Factors associated with 12-month discontinuation among contraceptive pill, patch, and ring users. Obstet Gynecol. 2013 Feb;121(2 Pt 1):330-336. doi: 10.1097/AOG.0b013e31827e5898.
Reference Type
RESULT
Vickery Z, Madden T, Zhao Q, Secura GM, Allsworth JE, Peipert JF. Weight change at 12 months in users of three progestin-only contraceptive methods. Contraception. 2013 Oct;88(4):503-8. doi: 10.1016/j.contraception.2013.03.004. Epub 2013 Mar 18.
Reference Type
RESULT
O'Neil-Callahan M, Peipert JF, Zhao Q, Madden T, Secura G. Twenty-four-month continuation of reversible contraception. Obstet Gynecol. 2013 Nov;122(5):1083-1091. doi: 10.1097/AOG.0b013e3182a91f45.
Reference Type
RESULT
Grunloh DS, Casner T, Secura GM, Peipert JF, Madden T. Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use. Obstet Gynecol. 2013 Dec;122(6):1214-21. doi: 10.1097/01.AOG.0000435452.86108.59.
Reference Type
RESULT
McNicholas CP, Madden T, Zhao Q, Secura G, Allsworth JE, Peipert JF. Cervical lidocaine for IUD insertional pain: a randomized controlled trial. Am J Obstet Gynecol. 2012 Nov;207(5):384.e1-6. doi: 10.1016/j.ajog.2012.09.018. Epub 2012 Sep 20.
Reference Type
RESULT
Leroy-Melamed M, Zhao Q, Belmonte MA, Archer J, Peipert JF. Contraceptive Preference, Continuation Rates, and Unintended Pregnancies in Patients with Comorbidities: A Prospective Cohort Study. J Womens Health (Larchmt). 2021 Oct;30(10):1469-1475. doi: 10.1089/jwh.2020.8536. Epub 2021 Jan 6.
Reference Type
DERIVED
Bernard C, Zhao Q, Peipert JF. Dual method use among long-acting reversible contraceptive users. Eur J Contracept Reprod Health Care. 2018 Apr;23(2):97-104. doi: 10.1080/13625187.2018.1445850. Epub 2018 Mar 27.
Reference Type
DERIVED
Related Links
Access external resources that provide additional context or updates about the study.
http://www.choiceproject.wustl.edu
CHOICE Project Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201101982
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
A Parent Child Program to Prevent Adolescent Pregnancy
NCT02333019
COMPLETED
NA
Latino Teen Pregnancy Prevention K23
NCT06105905
ENROLLING_BY_INVITATION
NA
Enhancing Male Participation in Interventions to Prevent Unintended Pregnancy
NCT03514914
COMPLETED
NA
Stage Matched Intervention to Increase Dual Method Use
NCT00436306
COMPLETED
PHASE4
Contraception Navigator Program
NCT05691270
COMPLETED
NA
Providing Birth Control Through Home Health Visits
NCT00065078
UNKNOWN
NA
A Patient-Directed Computerized Intervention to Address Reproductive Coercion
NCT06764030
COMPLETED
NA
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
NCT04371900
RECRUITING
NA
Gender Equity-Focused, Male-Centered Family Planning for Rural India
NCT01593943
COMPLETED
PHASE3
Reducing Adolescent Pregnancy
NCT04120376
COMPLETED
NA
Randomized Controlled Trial to Address Unintended Pregnancy Rates in Low Resource Settings
NCT05328648
COMPLETED
NA
Contraceptive Awareness and Reproductive Education
NCT01627574
COMPLETED
NA
Rigorous Evaluation of Let's Talk Birth Control
NCT06670066
NOT_YET_RECRUITING
NA
Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Families
NCT07214012
NOT_YET_RECRUITING
NA
Evaluation of Internet Access and Use in Adolescent Women Initiating Contraception
NCT00333541
COMPLETED
NA
Contraception Perspectives in Adolescents in Haiti
NCT05252052
COMPLETED
Evaluation of the Effectiveness of the Teen Options to Prevent Pregnancy (T.O.P.P.) Program
NCT01456793
COMPLETED
NA
Time to Conceive: A Study of Fertility
NCT01028365
COMPLETED
Testing the Impact of Two Posters on Contraceptive Knowledge, Contraceptive Preferences, and Perceived Pregnancy Risk
NCT03372369
COMPLETED
NA
Tennessee Youth Prepared for Success
NCT06001892
RECRUITING
NA
Expanded Prenatal Testing Options and Informed Choice
NCT00505596
COMPLETED
NA
Pilot Testing a New Pregnancy Decision Making Tool for Women With Physical Disabilities
NCT04651114
COMPLETED
NA
Jovenes Sanos: Preventing IPV and RC
NCT03660514
COMPLETED
NA
Louisville Teen Pregnancy Prevention Project
NCT01411878
COMPLETED
NA
Building Healthy Teen Relationships and Reproductive Practices to Increase Intervals Between Pregnancies
NCT00342706
COMPLETED
PHASE2